K. Rérat

410 total citations
12 papers, 290 citations indexed

About

K. Rérat is a scholar working on Neurology, Pathology and Forensic Medicine and Cognitive Neuroscience. According to data from OpenAlex, K. Rérat has authored 12 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 4 papers in Pathology and Forensic Medicine and 3 papers in Cognitive Neuroscience. Recurrent topics in K. Rérat's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (4 papers) and Multiple Sclerosis Research Studies (3 papers). K. Rérat is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (4 papers) and Multiple Sclerosis Research Studies (3 papers). K. Rérat collaborates with scholars based in France, Switzerland and Czechia. K. Rérat's co-authors include Vincent des Portes, Jeannie Visootsak, Barbara Koumaras, Sébastien Jacquemont, Gottfried Maria Barth, Liansheng Zhu, George Apostol, Florian von Raison, Elizabeth Berry‐Kravis and Randi J. Hagerman and has published in prestigious journals such as Science Translational Medicine, Journal of the Neurological Sciences and Multiple Sclerosis Journal.

In The Last Decade

K. Rérat

12 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Rérat France 8 153 140 130 65 43 12 290
Aaron D. Besterman United States 10 130 0.8× 52 0.4× 110 0.8× 13 0.2× 30 0.7× 24 338
Inês Carrilho Portugal 8 153 1.0× 75 0.5× 162 1.2× 79 1.2× 59 1.4× 20 362
Natalie A. Pride Australia 13 100 0.7× 69 0.5× 90 0.7× 375 5.8× 29 0.7× 21 473
Mahesh Mundalil Vasu Japan 8 105 0.7× 70 0.5× 197 1.5× 19 0.3× 21 0.5× 10 345
Maria Teresa Dotti Italy 13 60 0.4× 39 0.3× 205 1.6× 115 1.8× 147 3.4× 18 400
Miriam Kessi China 11 143 0.9× 44 0.3× 160 1.2× 62 1.0× 117 2.7× 34 440
Wout H. Deelen Netherlands 11 256 1.7× 87 0.6× 232 1.8× 46 0.7× 41 1.0× 16 413
Caroline A. Montojo United States 7 91 0.6× 119 0.8× 153 1.2× 48 0.7× 19 0.4× 10 313
Ivana Ricca Italy 10 123 0.8× 55 0.4× 156 1.2× 23 0.4× 74 1.7× 20 303
Raúl Alelú‐Paz Spain 9 70 0.5× 61 0.4× 151 1.2× 13 0.2× 44 1.0× 16 302

Countries citing papers authored by K. Rérat

Since Specialization
Citations

This map shows the geographic impact of K. Rérat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Rérat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Rérat more than expected).

Fields of papers citing papers by K. Rérat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Rérat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Rérat. The network helps show where K. Rérat may publish in the future.

Co-authorship network of co-authors of K. Rérat

This figure shows the co-authorship network connecting the top 25 collaborators of K. Rérat. A scholar is included among the top collaborators of K. Rérat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Rérat. K. Rérat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tourbah, Ayman, et al.. (2020). Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study. Multiple Sclerosis and Related Disorders. 46. 102433–102433. 1 indexed citations
2.
Ory‐Magne, Fabienne, Vanessa Rousseau, Michèle Puel, et al.. (2017). Cognitive complaint in early Parkinson's disease: A pilot study. Acta Neurologica Scandinavica. 137(1). 59–66. 17 indexed citations
3.
Berry‐Kravis, Elizabeth, Vincent des Portes, Randi J. Hagerman, et al.. (2016). Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Science Translational Medicine. 8(321). 321ra5–321ra5. 185 indexed citations
4.
Moreau, Thibault, Catherine Bungener, Olivier Heinzlef, et al.. (2016). Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study. European Neurology. 77(1-2). 47–55. 8 indexed citations
5.
Rérat, K., Fabrice Parker, Dominique Vidaud, et al.. (2015). Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1. Journal of the Neurological Sciences. 350(1-2). 98–100. 6 indexed citations
6.
Viallet, François, Christine Brefel‐Courbon, Franck Durif, et al.. (2013). Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation). Value in Health. 16(7). A622–A622. 2 indexed citations
7.
Gustavsson, Anders, et al.. (2012). Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France. Multiple Sclerosis Journal. 18(2_suppl). 17–22. 10 indexed citations
8.
Adams, David, Pierre Lozeron, Marie Théaudin, et al.. (2011). Varied patterns of inaugural light-chain (AL) amyloid polyneuropathy: a monocentric study of 24 patients. Amyloid. 18(sup1). 98–100. 18 indexed citations
9.
Damier, Philippe, François Viallet, M. Ziégler, I. Bourdeix, & K. Rérat. (2008). Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort. European Journal of Neurology. 15(7). 643–648. 3 indexed citations
10.
Azulay, Jean‐Philippe, et al.. (2008). Étude Précoce : évaluation d’un autoquestionnaire de dépistage et prise en charge précoces des fluctuations dans la maladie de Parkinson. Revue Neurologique. 164(4). 354–362. 8 indexed citations
11.
12.
Michon-Pasturel, U., K. Rérat, J Arvieux, et al.. (1998). Sclérose en plaques et anticorps antiphospholipides: étude consécutive de 62 patients. La Revue de Médecine Interne. 19(9). 635–639. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron D. Besterman Breakdown of academic impact, for papers by Inês Carrilho Breakdown of academic impact, for papers by Natalie A. Pride Breakdown of academic impact, for papers by Mahesh Mundalil Vasu Breakdown of academic impact, for papers by Maria Teresa Dotti Breakdown of academic impact, for papers by Miriam Kessi Breakdown of academic impact, for papers by Wout H. Deelen Breakdown of academic impact, for papers by Caroline A. Montojo Breakdown of academic impact, for papers by Ivana Ricca Breakdown of academic impact, for papers by Raúl Alelú‐Paz
Rankless by CCL
2026